LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Phenomenex
Phenomenex
Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers in industrial, government and academic laboratories. From drug discovery and pharmaceutical development to disease diagnosis, food safety to environmental analysis, Phenomenex chromatography solutions accelerate science and help researchers improve global health and well-being.
Tags
LC/MS
LC/MS/MS
Columns
Consumables
LinkedIn Logo

LC Columns for Prescribed (TDM) Drug Methods

RECORD | Already taken place We, 22.10.2025
Learn how polar C18 and biphenyl LC column chemistries impact drug analysis. Discover optimized LC-MS/MS methods for screening antipsychotics, antidepressants, and anticonvulsants.
Go to the webinar
Phenomenex: LC Columns for Prescribed (TDM) Drug Methods
Phenomenex: LC Columns for Prescribed (TDM) Drug Methods
Overview
  • During this presentation we will review:
  • The differences of fully porous polar C18 and core-shell biphenyl LC column chemistries
  • Analyte properties affect LC column retention and selectivity
  • LC-MS/MS methods for analysis of antipsychotics, antidepressants and anticonvulsants
  • Column solution for LC-MS screening of 48 TDM drug analytes for toxicology applications
Key Learning Points
  • Review selectivity and retention on polar C18 and biphenyl column chemistries for antipsychotic, antidepressant and anticonvulsant drugs
  • Learn how analyte properties for these drug classes affect LC column choice
  • Take a deep dive into optimized LC separations for screening and confirmation of antipsychotic, antidepressant and anticonvulsant drugs
Who Should Attend
  • Clinical and forensic toxicologists who want to know which columns to choose for their LC-MS/MS methods for TDM (prescribed) drugs in clinical research and forensic toxicology applications

Presenter: Stephanie J. Marin, Ph.D (Sr. Global Market Development Manager)

Stephanie J. Marin is the Applied Markets Global Market Development Manager at Phenomenex. She received her Ph.D. in chemistry from Arizona State University, and has expertise in sample preparation, liquid chromatography and mass spectrometry. Dr Marin has worked in marketing, product development, method development and method validation, in addition to customer facing roles in technical support, service, education and training. She has over 10 years of experience developing and validating clinical methods from her tenure at the ARUP Institute for Clinical and Experimental Pathology. She has also held positions as an Applications Chemist at Hamilton Company and Biotage, Marketing Manager at Selerity Technologies and as a Group Leader in analytical services for specialty chemicals and polymers at Rohm and Haas (now Dow). She was also a supervisor at an EPA certified laboratory. She is the author of over 30 peer reviewed publications and book chapters and over 100 abstracts presented at national and international meetings.

Phenomenex
LinkedIn Logo
 

Related content

Determination of Authenticity of Manuka Honey Using the MALDI-8030 Benchtop Linear MALDI-TOF Mass Spectrometer

Applications
| 2026 | Shimadzu
Instrumentation
MALDI, LC/MS, LC/TOF
Manufacturer
Shimadzu
Industries
Food & Agriculture

Analysis of Inorganic Anions in Drinking Water According to EPA Method 300.1 Using Nexera IC -Part A

Applications
| 2026 | Shimadzu
Instrumentation
Ion chromatography
Manufacturer
Shimadzu
Industries
Food & Agriculture

Quality Evaluation of mRNA by Electrophoresis

Applications
| 2026 | Shimadzu
Instrumentation
Capillary electrophoresis
Manufacturer
Shimadzu
Industries
Pharma & Biopharma

LC/MS dMRM Method Refinement Expands Targeted Lipidomics Studies from Plasma to Cells and Tissues

Applications
| 2026 | Agilent Technologies
Instrumentation
LC/MS, LC/MS/MS, LC/QQQ
Manufacturer
Agilent Technologies
Industries
Lipidomics, Clinical Research

Sensitive Detection of Aflatoxins by the Agilent 1290 Infinity III Fluorescence Detector

Applications
| 2026 | Agilent Technologies
Instrumentation
HPLC
Manufacturer
Agilent Technologies
Industries
Food & Agriculture
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike